Our post-doctoral researcher Dr. Cansel Vatansever’s research project “Modification of Hypervirulant Klebsiella pneumoniae virulence with CRISPR/Cas9 for real-time monitorization of sepsis pathogenesis in an in vivo mouse sepsis model” was approved as a TUBITAK 1001 project.
We congratulate our researcher.
